Scientists have good news for patients who suffer from currently untreatable dry age-related macular degeneration (dry AMD). In a new study, researchers identified a potential target for future therapies to slow the progression of the blinding condition. Published in Investigative Ophthalmology & Visual Science, the findings indicate that treatments currently used for other conditions could also work for dry AMD.
New study shows that ranibizumab used in a treat-and-extend regimen cuts clinic visits by 46% for patients with Diabetic Macular Oedema
Data from a new study shows that ranibizumab (Lucentis®) used in a treat-and-extend (T&E) regimen cuts clinic visits by 46% for patients with Diabetic Macular Oedema (DMO) – one of the leading…
Uncategorized
Second Sight reports 265% increase in revenue in third quarter
Second Sight Medical Products reported $2.2 million in net revenue in the third quarter, a 265% increase compared with $609,000 in the same quarter of 2014, according to a press release. The increase was attributed to a higher number of implanted Argus…
Uncategorized
VIDEO: Why how and when to trust intraoperative aberrometry
NEW YORK — At OSN New York 2015, John P. Berdahl, MD, goes into detail about the advantages of intraoperative aberrometry and how the technology provides valuable data that improves refractive outcomes in cataract surgery.
Tobii AB Interim Report Q3 2015
STOCKHOLM–(BUSINESS WIRE)–Regulatory News: Tobii AB (Nasdaq Stockholm: TOBII) today reported its results for the third quarter of 2015. Continued good progress in all business units July – September · The Group’s sales totaled SEK 228 million (168), an increase of SEK 60 million or 36%, of which SEK 30 million was currency effects and SEK 30 million was organic growth. · Gross margin was 72% (71%). · The Group’s operating loss amounted to SEK -8 million (-21). · The combined operating profit
Uncategorized
Micro-thin DSAEK improves vision with low risk of graft detachment
Micro-thin Descemet’s stripping automated endothelial keratoplasty yielded visual outcomes comparable to those of other endothelial keratoplasty techniques using thin grafts, according to a study.The prospective study included 130 eyes of 114 patients who underwent micro-thin DSAEK; 53% of cases underwent combined phacoemulsification and DSAEK.